INTRODUCTION
============

Congenital malformations comprise 2-3% of all human live births, being one of the major causes of childhood mortality in developed countries. The oral clefts are the most common craniofacial anomaly in humans, affecting approximately one in every 500 to 1,000 live births worldwide[@B25]. In Brazil, the estimated prevalence is 0.36 in 1,000 live births and the Southeast region shows a prevalence of 0.34 *per* 1,000 live births[@B27].

Besides the facial abnormalities, individuals affected present several complications such as speech, hearing and dental disorders. Associated defects, especially involving cardiovascular, central nervous and musculoskeletal systems, are commonly seen, as well as the psychosocial effects from the malformation experienced lifelong[@B18].

The oral clefts arise from failure of normal craniofacial developmental processes that require the coordination of a complex series of events involving cell growth, migration, differentiation, and apoptosis[@B18]. Nonsyndromic oral clefts are observed in approximately 70% of the cases, occurring as an isolated condition unassociated with any other recognizable anomalies[@B28]. In Brazil, this defect is considered a problem of public health, since about 4,000 new cases are expected every year[@B4].

The nonsyndromic oral clefts are composed of two separate entities: cleft lip with or without cleft palate (CL±P) and cleft palate only (CP). Moreover, evidences show that CL±P and CP are developmentally distinct entities. Despite the efforts that have been made to elucidate the oral clefts etiology, the understanding about nonsyndromic variants still remains unknown[@B11]. In general, nonsyndromic oral clefts are considered being from a multifactorial origin, involving mainly environmental and genetic components[@B25]. Regarding the environmental components, mother's habits such as alcohol intake and smoking during pregnancy are pointed out as risk factors to oral clefts[@B17]. On the other hand, recent advances into both genetics and molecular biology fields have been decisive for promoting an increase in the knowledge about the basis of craniofacial development, bringing a number of genes associated with mammals cleft development.

Several candidate genes have been investigated to identify some association with nonsyndromic clefts, including growth factors such as EGF[@B5] ^,^ [@B24]. A single gene on chromosome 4q25-q27 encodes the epidermal growth factor (EGF). EGF has an effect on the differentiation and is a potent mitogenic factor for a variety of cultured cells of both ectodermal and mesodermal origin. The protein EGF binds to its receptor (EGFR), leading to a signaling transduction cascade activation that will ultimately influence cell proliferation, inhibition of apoptosis and differentiation. EGF is expressed in several developing organs and it has been implicated to play roles in odontogenesis[@B15], mandibular morphogenesis[@B30], embryogenesis and also normal palate development[@B13].

It has been suggested that EGF contributes to a successful fusion of the facial prominences and outgrowth of the primary palate[@B13]. Also, changes in EGF expression affecting the proliferation of epithelial cells have been related to cleft palate development[@B1].

Genetic variations in the EGF may lead to an alteration in the protein production and activity, affecting an individual susceptibility to many types of conditions, including oral clefts. A single nucleotide polymorphism (SNP) in the 5\' untranslated region of the gene (rs 4444903; g.109912954A\>G - HGVS nomenclature) was identified and characterized by an A to G transversion found 61bp downstream of the EGF transcription start site (EGF+61 A\>G). In vitro analysis suggested changes in EGF expression levels caused by this base substitution[@B29]. The functional EGF+61 A\>G polymorphism is the most widely studied variation in the EGF gene and it has been associated with increased risk of many types of cancer, including melanoma[@B29], glioma[@B12], hepatocellular carcinoma[@B21], among others. Interestingly, some reports have observed the association between congenital malformation and cancer[@B7] ^,^ [@B8], suggesting that the individuals born with oral clefts have a higher susceptibility for cancer, raising the hypothesis that, in some instances, these two conditions share common molecular pathways.

Afterwards, considering the potential implication of EGF gene polymorphism affecting the normal craniofacial development and its relation with cancer susceptibility, we assessed the association between the functional EGF+61 A\>G variation and nonsyndromic oral clefts risk in a Brazilian population.

MATERIAL AND METHODS
====================

Subjects
--------

The local Research and Ethics Committee approved this study under protocol number 0132.314.000-09. Informed consent was obtained from all participating individuals or parents/legal guardians.

Two hundred eighteen (218) patients with cleft and in absence of any known cleft associated syndrome were recruited (mean age: 17.2±10.8 years old). None of the index cases were diagnosed with median cleft. Index cases were ascertained through the Hospital Municipal Nossa Senhora do Loreto (Reference Hospital for Oral Cleft Treatment), located in Rio de Janeiro, Brazil.

The determination of the cleft phenotype was based on the clinical examination. Cleft status was based on cleft laterality (left, right and bilateral) and cleft severity (comprised of primary and secondary palates entirely). Abbreviations for cleft type classifications were attributed as follows: CL - cleft lip; CP - cleft palate only; CLP - cleft lip and palate; CL±P - cleft lip+cleft lip and palate excluding cleft palate only.

Tooth agenesis was considered when at least one developmentally missing permanent tooth was observed. This condition represents an important factor in the cleft subphenotypes determination. Only dental anomalies outside the cleft area were considered for CL and CLP. For the CP subjects, all dental anomalies observed were considered. Dental anomalies adjacent to the cleft area (affecting maxillary central incisors, lateral incisors, or canines) were not included in this study because the absence of such teeth may be the consequence of developmental anomalies at the cleft site[@B19].

The control group (n=253) was selected among patients and workers in School of Dentistry at Federal University of Rio de Janeiro (mean age: 20.4±16.4 years old). Individuals were eligible as a control only if they had no congenital malformations, dental anomalies and family history of oral clefts.

All the evaluated subjects were recruited from July to December 2009. Epidemiological data such as ethnicity, family history of clefts and mother's habits during pregnancy including cigarette smoking and alcohol consumption were obtained by standardized questionnaires. The ethnicity definition was ascertained based on self-reported information. Both institutions where the subjects were recruited are located in the Rio de Janeiro state, in the Southeast of Brazil, one of the most densely populated and industrialized regions of the country. This region comprises an ethnic admixture of Caucasians (47.4%) and African descent (52.0%). The remaining 0.6% of the population is of Amerindian or Asian descent[@B9].

PCR-RFLP
--------

Genomic DNA for molecular analysis was extracted from cells detached of oral mucosa by mouthwash using SDS and proteinase k digestion[@B16]. The purified DNA was used to determine the EGF +61A\>G polymorphism using the polymerase chain reaction - restriction fragment length polymorphism (PCR-RFLP) technique as previously described[@B29]. The PCR reaction was carried out in 30 µL mix containing 160 ng of genomic DNA, 1x Dream Taq Buffer (Fermentas, Maryland, USA), 0.2 mM of dNTPs (Fermentas, Maryland, USA), 0.3 µM of each primer (Forward: 5' TGTCACTAAAGGAAAGGAGG3'; Reverse: 5' TTCACAGAGTTTAACAGCCC 3' -- Invitrogen, CA, USA) and 1 U Dream Taq DNA Polymerase (Fermentas, Maryland, USA). The cycling conditions comprised an initial denaturation step for 10 min at 96°C, followed by 44 cycles consisting of three steps: 96°C for 30 s, 61°C for 30 s and 72°C for 1 min. A final extension step was performed at 72°C for 10 min. The fragment amplified (242bp) was digested with 2 U of Alu I (New England Biolabs, Maryland, USA) at 37°C overnight, electrophoresed on a 2.5% agarose gel stained with ethidium bromide and photographed under UV illumination. The digestion produced four fragments (15, 34, 91 and 102bp) when the A allele was present and three fragments (15, 34 and 193 bp) in the presence of the G allele.

Statistical analysis
--------------------

The data were processed and analyzed by using the GraphPad Instat (version 6.0) software. Odds ratio calculations and χ2 or Fisher's exact tests at a level of significance of 0.05 were used to determine if any phenotype and subphenotype of oral cleft was preferentially associated with EGF genotypes and alleles. Moreover, the Hardy-Weinberg equilibrium was tested by the χ2 test, comparing the observed versus the expected genotype frequencies.

RESULTS
=======

The characteristics of the studied population are summarized in [Table 1](#t1){ref-type="table"}. Out of the 471 individuals included in the study, 218 presented clefts and 253 did not (controls). In the cleft group, 87.6% had CL±P (20.4% of CL and 79.6% of CLP) and 12.4 % had CP.

Table 1Descriptive characteristics of cleft patients and controlsPopulation characteristics CleftControls (n=253)p\* (n=218)  Gender, n (%)   Female104 (47.7)138 (54.5)0.14Male114 (52.3)115 (45.5) Ethnicity, n (%)   Caucasian128 (58.7)153 (60.5)0.70African descent90 (41.3)100 (39.5) Mother\'s habits during pregnancy, n (%)   Cigarette smoking46 (21.1)37 (14.6)0.07Alcohol consumption26 (11.9)16 (6.3)**0.04Cleft group characteristics** **CLCLPCP** (n=39)(n=152)(n=27)Cleft side, n (%)   Left24 (61.6)70 (46.1)-Right10 (25.6)33 (21.7)-Bilateral5 (12.8)49 (32.2)-Severity of cleft, n (%)   Complete-148 (97.4)22 (81.5)Incomplete-4 (2.6)5 (18.5)Associated tooth agenesis, n (%)4 (10.5)22 (14.4)2 (7.4)Positive cleft family history, n (%)8 (21.1)38 (24.8)4 (14.8)[^1][^2]

The occurrence of cleft was associated to maternal alcohol consumption during pregnancy (p=0.04). The distribution of cleft type was statistically different according to gender with CP being more prevalent than CLP in females ([Table 2](#t2){ref-type="table"}). Considering the distribution of cleft type and laterality (bilateral or unilateral) or cleft severity (complete or incomplete) according to gender, no statistical differences were detected (data not shown).

Table 2Distribution of cleft type according to genderCleft typeCLCLPCPp\*Gender(n=39)(n=152)(n=27) Males, n (%)16 (41.0)89 (58.6)9 (33.3)     **0.02**Females, n (%)23 (59.0)63 (41.4)18 (66.7) [^3][^4][^5][^6][^7]

Genotype distribution in cleft cases and controls was compared to evaluate the EGF+61 polymorphism association with clefts susceptibility. The banding patterns of PCR-RFLP EGF+61 A\>G polymorphism are showed in [Figure 1](#f01){ref-type="fig"}.

Figure 1PCR-RFLP of EGF+61 A\>G polymorphism. Agarose gel electrophoresis of EGF DNA fragments stained with ethidium bromide. Lane 1:100bp DNA Ladder; Lanes 2-5, 8 and 9: heterozygous AG; Lanes 6 and 7: homozygous AA; Lane 10: homozygous GG. PCR-RFLP: polymerase chain reaction - restriction fragment length polymorphism; EGF: epidermal growth factor

The polymorphism genotype distributions in cases and controls were shown in [Table 3](#t3){ref-type="table"} and were consistent with those predicted from the Hardy-Weinberg equilibrium. The heterozygous AG was the most frequent genotype in both studied groups. The distributions of genotypes and alleles were similar, considering all cleft cases versus controls and CL±P cases versus controls ([Table 3](#t3){ref-type="table"}). The same similarity was observed when all cleft cases and controls were stratified by ethnicity in Caucasian and African descents (blacks and mulattos) and compared (p=0.063 and p=1.000, respectively) (data not shown). The AA genotype frequency in CP patients was lower than in the control group, showing a borderline p value (p=0.054).

Table 3Association between EGF+61 A\>G polymorphism and clefts riskSubjectsnAlleles n (%)p\*OR (95%CI)Genotypes n (%)p\*  AG  AAAGGG Controls253252 (49.8)254 (50.2)-Reference60 (23.7)132 (52.2)61 (24.1) All Clefts218224 (51.4)212 (48.6)0.651.06 (0.82-1.38)52 (23.9)120 (55.0)46 (21.1)0.72Cleft Type         CL±P191201 (52.6)181 (47.4)0.421.12 (0.86-1.46)50 (26.2)101 (52.9)40 (20.9)0.68CP2723 (42.6)31 (57.4)0.320.75 (0.42-1.32)2 (7.4)19 (70.4)6 (22.2)0.11Cleft Subphenotype         Bilateral CL±P5459 (54.6)49 (45.4)0.400.82 (0.54-1.25)16 (29.6)27(50.0)11 (20.4)0.63Unilateral CL±P137142 (51.8)132 (48.2)0.600.92 (0.69-1.24)34 (24.8)74 (54.0)29 (21.2)0.80Left CL±P9498 (52.1)90 (47.9)0.610.91 (0.65-1.27)20 (21.3)58 (61.7)16 (17.0)0.24Right CL±P4344 (51.2)42 (48.8)0.910.93 (0.60-1.50)14 (32.6)16 (37.2)13 (30.2)0.19Cleft with tooth agenesis2831 (55.4)25 (44.6)0.481.25 (0.72-2.18)8 (28.6)15 (53.6)5 (17.8)0.71[^8][^9]

The frequency of the A allele was higher in bilateral CL±P patients (54.6%), cleft cases with tooth agenesis (55.4%) and cleft cases presenting family history of cleft (56.3%) (data not shown) than in the control group, but no statistically significant differences were found. The AA genotype was over-represented in both bilateral CL±P and patients with family history of cleft than in controls; the same pattern of genotype distribution was observed considering maternal smoking during pregnancy (23.9% and 16.2% in cases and controls, respectively; data not shown) but we did not detect any statistical difference.

Comparing the different entities of nonsyndromic oral clefts (CL±P versus CP), we noticed that the allele G was most frequent in CP cases (57.4%) compared with CL±P cases (47.4%) ([Table 3](#t3){ref-type="table"}). This difference was statistically significant (p=0.03).

DISCUSSION
==========

To the best of our knowledge, we here present the first associative study assessing the EGF+61 A\>G polymorphism and nonsyndromic oral clefts risk. According to Shahbazi, et al.[@B29] (2002), this variant may act as a functional polymorphism since the base substitution can lead to changes in the EGF protein production. Moreover, the association of this polymorphism with clinical disorders including cancer has been described. Since cancer and oral clefts may share the same molecular pathways, the EGF+61 A\>G polymorphism could be associated with nonsyndromic oral clefts risk.

The relationship between the EGF+61 A\>G polymorphism and cancer susceptibility is known, as well as the fact that risk allele vary between distinct ethnicities. The G allele and GG genotype were associated with increased risk for gliomas in the European population and represent protective factors in the Chinese population[@B12] ^,^ [@B32]. Considering a Brazilian population from Rio de Janeiro, a high risk for gliomas was associated with the A allele and AA genotype[@B31].

According to our results when evaluating nonsyndromic oral cleft patients, the A allele and AA genotype were over-represented in cleft cases compared to control group when we considered the bilateral CL±P cases, cleft cases with tooth agenesis and cleft cases presenting family history of cleft. However, we did not observe a statistically significant difference. By interpreting these results, one limitation of our study could be the sample size that is still small and may not provide sufficient statistical power to estimate the association between EGF+61 A\>G polymorphism and nonsyndromic oral cleft susceptibility in the population evaluated. Ardinger, et al.[@B5] (1989) also failed to confirm the association between two others EGF gene variations and nonsyndromic oral clefts.

The frequencies of several alleles vary significantly between populations, consistent with the possibility of false associations in case-control studies due to ethnic admixture. Any polymorphism found by chance at a higher frequency in a specific subgroup will appear to be associated with disease and will likely be a false positive. The Brazilian population is multi-ethnic, consisting mainly of people from European, African, and South Amerindian origin, being one of the most heterogeneous population in the world. Not surprisingly, our population presents large levels of genetic admixture. A study predicting the level of Brazilians African ancestry estimated by molecular biomarkers showed the Brazilian population presents African ancestry values intermediate between Europeans and Africans. Moreover, the southeast region of the country showed the most pronounced level of admixture. To prevent false-positive associations, the studied population in the present work was stratified in two different ethnic groups and the polymorphism frequencies were evaluated. The alleles' distribution were similar between whites (Caucasian) and non-whites (mulattos and blacks).

Genetic predisposition studies on human populations have demonstrated that CL±P and CP have distinct genetic backgrounds. In the present study, the EGF genotype distribution between CL±P and CP patients was statistically different being the AA genotype over-represented in CL±P cases and the GG genotype more common in CP cases. Genome Wide Association Studies (GWAS) have been identified several loci related with CL±P susceptibility such as 1q32, 8q24, 10q25, 17q22, 2p21, 13q31, and 15q22[@B22] ^,^ [@B23]. However, the same relationship was not confirmed when CP cases were assessed[@B23], suggesting that these clefting phenotypes have distinct etiologies and supporting the historical separation of CL±P from CP.

Despite different research groups have performed notable attempts in the last decades to locate nonsyndromic clefts loci in the human genome, advances are still modest. The inheritance cannot be explained by a Mendellian simple model, displaying a very familial aggregation, which reveals the presence of an important genetic component. Mutations associated with genes of the EGF superfamily are implicated in malformations arising from abnormal development of the first branchial arch[@B5]. Also, it was suggested the EGF as candidate gene to clefting since it plays a role in normal and abnormal palatogenesis in rodents[@B1] ^,^ [@B13].

The possible interaction between EGF and other clefting-related genes in the same pathway, such as EGFR and TGFA (Transforming Growth Factor Alpha), may contribute to the nonsyndromic oral clefts susceptibility. It has been suggested that EGF, TGFA and EGFR play a role in cell proliferation and differentiation during primary palate morphogenesis which would then be relevant to clefting[@B13]. The teratogenic 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure has been shown to disrupt EGF, EGFR and TGFA expression in the mice palate affecting the proliferation and differentiation of the medial epithelial cells resulting in cleft palate[@B1].

Overall, TGFA as well as IRF6 are considered as genetic clefting modifiers in humans. However, mutations in TGFA gene were not associated with nonsyndromic cleft lip and palate in the Brazilian population[@B6] and the role of IRF6 in our population is still unclear[@B10]. On the other hand, some variations such as polymorphisms in MMP3 and its inhibitor TIMP2[@B20], BMP4[@B2], and some markers discovered by GWAS, such as 1p36, 15q22 and 17p22[@B4] showed significant associations with nonsyndromic oral clefts in recent studies with individuals from Brazil. A BMP4 polymorphism was also associated with upper lateral incisor agenesis considered a microform of CL in a Southeast Brazilian population[@B3].

The association of a number of environmental factors and cleft risk has been reported, including maternal alcohol intake during pregnancy[@B14]. In the present study, we observed a relation between the increase of odds for CL±P and CP and maternal exposure to alcohol, in agreement with results obtained in a Brazilian case-control study[@B17].

Another well-established environmental factor for cleft risk is maternal smoking during pregnancy[@B14]. Despite the high frequency of the AA genotype in cleft cases considering mother´s cigarette smoking during pregnancy in the present study, maternal smoking was not associated with EGF +61 A\>G polymorphism and the nonsyndromic oral clefts risk.

It has been proposed that tooth agenesis outside the cleft area could serve as marker for the definition of cleft subphenotypes[@B19]. So, we included tooth agenesis as a subgroup of oral cleft and observed that the A allele was more frequent in the cleft cases with tooth agenesis compared with controls, with no statistical difference.

In summary, our data suggest that the EGF+61 A\>G polymorphism was not related with nonsyndromic oral cleft susceptibility in a population from the Southeast of Brazil. However, our results supported a different genetic background between CL±P and CP. The potential effect of maternal alcohol intake on cleft risk was confirmed. Further larger sample-sized studies improving the statistical power and using high-throughput screening methods are needed to elucidate the role of this and others SNPs in candidate genes as contributors to nonsyndromic oral clefts risk.
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[^1]: \*Fisher\'s exact test

[^2]: CL: cleft lip; CLP: cleft lip and palate; CP: cleft palate only

[^3]: \*Chi-square test

[^4]: CL versus CLP: p=0.07 (Fisher\'s exact test)

[^5]: CL versus CP: p=0.61 (Fisher\'s exact test)

[^6]: CLP versus CP: ***p=0.02*** (Fisher\'s exact test)

[^7]: CL: cleft lip; CLP: cleft lip and palate; CP: cleft palate only

[^8]: \*Fisher's exact test or chi-square test

[^9]: EGF: epidermal growth factor; CL±P: cleft lip+cleft lip and palate excluding cleft palate only; CP: cleft palate only
